Ebola Patient Released from Hospital in Rome

Italy's only Ebola patient is fully recovered and was released from hospital on Friday more than a month after being flown to Rome from Sierra Leone where he worked as a doctor treating others

Join Our Community of Science Lovers!

By Steve Scherer

ROME (Reuters) - Italy's only Ebola patient is fully recovered and was released from hospital on Friday more than a month after being flown to Rome from Sierra Leone where he worked as a doctor treating others stricken by the disease.

The 50-year-old Sicilian man has been identified only by his first name, Fabrizio. He contracted the hemorrhagic virus while working for humanitarian group Emergency during the worst Ebola outbreak on record.

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

"For the first few days, partly to keep my mind active, I tried to examine every symptom I was experiencing scientifically," Fabrizio told reporters in his first public appearance since contracting the disease.

"Then there came a moment when I lost consciousness of what was going on around me and I don't remember anything that happened for about two weeks," he said, thanking those who cared for him during his illness.

He said that after he regains his strength he may return to Sierra Leone to continue treating Ebola patients. Ebola survivors are generally believed to be immune to future infection from the strain that made them sick.

His blood, which contains antibodies that fight the virus, will be sent to Sierra Leone to help in treatment, a doctor who treated Fabrizio at the Lazzaro Spallanzani hospital said.

The virus is still spreading in West Africa, especially in Sierra Leone, and the number of known cases globally has exceeded 20,000, with 7,905 dead, the World Health Organization (WHO) said on Wednesday.

After his arrival in Rome on Nov. 25, the patient's condition worsened and he was moved to intensive care on Dec. 5, where he received respiratory assistance.

He was treated with a combination of an experimental drug never used before in Italy, and plasma taken from survivors of the disease.

(Writing by Steve Scherer; Editing by Toby Chopra)

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American